scholarly journals Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification

2016 ◽  
Vol 124 (10) ◽  
pp. 699-710 ◽  
Author(s):  
Tommaso Bizzarro ◽  
Maurizio Martini ◽  
Sara Capodimonti ◽  
Patrizia Straccia ◽  
Celestino Pio Lombardi ◽  
...  
2016 ◽  
Vol 5 (5) ◽  
pp. S84-S85
Author(s):  
Esther Rossi ◽  
Tommaso Bizzarro ◽  
Maurizio Martini ◽  
Celestino Lombardi ◽  
Alfredo Pontecorvi ◽  
...  

2016 ◽  
Vol 124 (12) ◽  
pp. 893-900 ◽  
Author(s):  
Xiaoyin “Sara” Jiang ◽  
Grant P. Harrison ◽  
Michael B. Datto

2018 ◽  
Vol 50 (10) ◽  
pp. 735-737 ◽  
Author(s):  
Pedro Rosario ◽  
Alexandre da Silva ◽  
Maurício Nunes ◽  
Michelle Borges

AbstractRecently, the American College of Radiology (ACR) proposed a Thyroid Imaging Reporting and Data System (TI-RADS) for thyroid nodules based on ultrasonographic features. It is important to validate this classification in different centres. The present study evaluated the risk of malignancy in solid nodules>1 cm using ACR TI-RADS. The risk of malignancy was defined including noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) and after its exclusion from malignant tumours. For the present study, the original images were revised, and each nodule was assigned to one of the TI-RADS levels proposed for solid nodules: TR3, TR4, or TR5. This risk of malignancy was significantly different for the three levels: 1.7%, 11.2%, and 60.6% for TR3, TR4, and TR5, respectively, when NIFTP was included, and 0.6%, 7.9%, and 60.2% for TR3, TR4, and TR5, respectively, when NIFTP was excluded from malignant tumours. The nodules corresponding to NIFTP were classified according to ACR as TR3 in 28.5% of cases, TR4 in 67.8%, and TR5 in only 3.5%. The nodules corresponding to cancer were classified according to ACR as TR3 in only 2.3% of cases, TR4 in 27%, and TR5 in 70.5%. In conclusion, this study shows the validity of the ACR TI-RADS for solid thyroid nodules, even after the exclusion of NIFTP from malignant tumours.


2017 ◽  
Vol 46 (2) ◽  
pp. 139-147 ◽  
Author(s):  
Tamar C. Brandler ◽  
Joseph Yee ◽  
Fang Zhou ◽  
Margaret Cho ◽  
Joan Cangiarella ◽  
...  

2022 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Xiaofeng Ni ◽  
Shangyan Xu ◽  
Benyan Zhang ◽  
Weiwei Zhan ◽  
Wei Zhou

Sign in / Sign up

Export Citation Format

Share Document